Hydrogels for hMSC delivery & engraftment
Hydrogels for hMSC delivery & engraftment
批准号:
9112785
负责人:
Andres J Garcia
金额:
$30.29万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2018-07-31
关键词:
AdhesivesAnimal ModelBiocompatible MaterialsBolus InfusionBone RegenerationBone TissueCartilageCell AdhesionCell CountCell SurvivalCell TherapyCellsClinicalClinical TrialsCollagenCulture MediaDefectEngineeringEngraftmentExhibitsFibronectinsFormulationGene ExpressionHistocytochemistryHome environmentHumanHydrogelsImmunodeficient MouseImmunohistochemistryImplantIntegrin BindingIntegrin-mediated Cell Adhesion PathwayIntegrinsIntervertebral disc structureLigandsLuciferasesMechanicsMesenchymal Stem CellsMonitorMusculoskeletalOsseointegrationOsteocalcinOsteogenesisOutcomePeptide HydrolasesPeptidesPre-Clinical ModelRadialRattusRecombinantsRegenerative MedicineReporterResearchSignal TransductionSourceSpecificityStem Cell ResearchStem cellsSystemTestingTissue EngineeringTissuesTransplantationVariantVascular Endothelial Growth FactorsVascularizationWorkbasebonedensityethylene glycolimprovedin vivoin vivo imaginginjuredinnovationmimeticsnovelosteoblast differentiationosteogenicparacrinepromoterreceptorrepairedself-renewal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mesenchymal stem cells (MSC) represent a promising cell source for regenerative medicine applications. Transplanted MSC enhance bone, cartilage, and intervertebral disc repair in pre-clinical models and initial clinical trials. Howevr, the engraftment of transplanted MSC is extremely low, and the beneficial effects are generally attributed to trophic/paracrine actions. The low engraftment and survival of transplanted MSC significantly limit these cell-based therapies in the repair of challenging, non-healing defects. A
major hurdle to MSC survival and engraftment is the lack of appropriate bioactive delivery vehicles. The objective of this project is to engineer biofunctional hydrogels to direct human MSC (hMSC) survival, engraftment, and function. Our central hypothesis is that hydrogels presenting integrin-specific adhesive ligands will promote hMSC engraftment, osteogenesis, and bone repair. This work will establish bioactive cell delivery vehicles that enhance MSC survival, engraftment and function compared to existing synthetic matrices. Aim 1: Engineer hydrogels presenting integrin-specific adhesive ligands to direct hMSC fate commitment and differentiation. Aim 2: Evaluate the ability of integrin-specific hydrogels to promote hMSC survival, engraftment, and bone repair. Aim 3: Analyze the effects of VEGF co-delivery from hydrogels on hMSC engraftment and bone repair. The proposed research is innovative because it focuses on exploiting integrin binding specificity to control hMSC survival, engraftment and function for bone repair and integrates new in vivo imaging approaches. This work is expected to yield the following outcomes. First, we will determine the extent to which integrin-specific ligands regulate hMSC signaling, commitment and differentiation into osteogenic, adipogenic and chondrogenic lineages. We will also establish novel bioactive cell delivery vehicles that enhance MSC survival, engraftment and bone formation for improved bone repair. Finally, because of the transformative potential of MSC, this research will have broad significance and impact to many regenerative medicine applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogels for human beta cell survival, function and evasion of immune rejection
-
批准号:10512947
-
项目类别:
-
资助金额:$82.23万
-
财政年份:2022
-
负责人:Andres J Garcia
-
依托单位:
Hydrogels for human beta cell survival, function and evasion of immune rejection
-
批准号:10865870
-
项目类别:
-
资助金额:$8.27万
-
财政年份:2022
-
负责人:Andres J Garcia
-
依托单位:
Hydrogels for human beta cell survival, function and evasion of immune rejection
-
批准号:10705265
-
项目类别:
-
资助金额:$77.29万
-
财政年份:2022
-
负责人:Andres J Garcia
-
依托单位:
BIOMATERIALS FOR STEM CELL DERIVED BETA CELL TRANSPLANTATION
-
批准号:10517827
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2021
-
负责人:Andres J Garcia
-
依托单位:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
-
批准号:10684716
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2021
-
负责人:Andres J Garcia
-
依托单位:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
-
批准号:10306891
-
项目类别:
-
资助金额:$40.76万
-
财政年份:2021
-
负责人:Andres J Garcia
-
依托单位:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
-
批准号:10557968
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2021
-
负责人:Andres J Garcia
-
依托单位:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
-
批准号:10905940
-
项目类别:
-
资助金额:$5.94万
-
财政年份:2021
-
负责人:Andres J Garcia
-
依托单位:
Targeted delivery of immunomodulatory biologics for induction of immune privilege to allogeneic pancreatic islet grafts
-
批准号:10227259
-
项目类别:
-
资助金额:$42.1万
-
财政年份:2020
-
负责人:Andres J Garcia
-
依托单位:
Hydrogels for delivery of muscle stem cells to diaphragm
-
批准号:10281444
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2020
-
负责人:Andres J Garcia
-
依托单位:
Targeted delivery of immunomodulatory biologics for induction of immune privilege to allogeneic pancreatic islet grafts
-
批准号:10163042
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2020
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10158891
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)
-
批准号:10200504
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10158624
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:9987140
-
项目类别:
-
资助金额:$41.97万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10210461
-
项目类别:
-
资助金额:$852.35万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10001635
-
项目类别:
-
资助金额:$882.05万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:9752684
-
项目类别:
-
资助金额:$848.26万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10424822
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
Georgia Clinical & Translational Science Alliance (GaCTSA)
-
批准号:10459812
-
项目类别:
-
资助金额:$152.09万
-
财政年份:2017
-
负责人:Andres J Garcia
-
依托单位:
海外基金